Tags: Drug.

Bucindolol is a non-selective beta blocker with additional weak alpha-blocking properties and some intrinsic sympathomimetic activity. It was under review by the FDA in the United States for the treatment of heart failure in 2009 .

Bucindolol.png
ATC prefix
none
CAS number
71119-11-4
FDA UNII code
E9UO06K7CE
IUPAC name
2-[2-hydroxy-3-[[2-(1H-indol-3-yl)-11-dimethyl-ethyl]amino]propoxy]benzonitrile
PubChem
51045

Loading...

This page contains content from the copyrighted Wikipedia article "Bucindolol"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.